• SPX
  • 6075.11
  • -0.19 %
  • -11.3804
  • DJI
  • 44765.71
  • -0.55 %
  • -248.3281
  • N225
  • 38974.31
  • -1.07 %
  • -421.07
  • FTSE
  • 8349.38
  • 0.16 %
  • 13.5703
  • IXIC
  • 19700.2586
  • -0.18 %
  • -34.86
VolitionRx Limited (VNRX) Stock Price, News & Analysis

VolitionRx Limited (VNRX) Stock Price, News & Analysis

Currency in USD Disclaimer

$0.5700

-$0

(-0.18%)

Day's range
$0.52
Day's range
$0.59
50-day range
$0.52
Day's range
$0.9
  • Country: US
  • ISIN: US9286611077
52 wk range
$0.43
Day's range
$1.23
  • CEO: Mr. Cameron Reynolds MBA
  • Website: Visit Site


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score -33.71
  • Piotroski Score 3.00
  • Grade Buy
  • Symbol (VNRX)
  • Company VolitionRx Limited
  • Price $0.57
  • Changes Percentage (-0.18%)
  • Change -$0
  • Day Low $0.52
  • Day High $0.59
  • Year High $1.23

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company operates Nucleosomics a technology platform for blood test. VolitionRx Limited is based in Austin, Texas.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 03/12/2025
  • Fiscal Year End N/A

  • Average Stock Price Target $0.00
  • High Stock Price Target $0.00
  • Low Stock Price Target $0.00
  • Potential Upside/Downside N/A
  • Consensus Rating Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$0.45
  • Trailing P/E Ratio -1.51
  • Forward P/E Ratio -1.51
  • P/E Growth -1.51
  • Net Income $-35,319,078

Income Statement

Quarterly

Annual

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

VolitionRx Limited Frequently Asked Questions

  • What were the earnings of VNRX in the last quarter?

    In the last quarter VolitionRx Limited earnings were on Wednesday, August, 14th. The VolitionRx Limited maker reported -$0.08 EPS for the quarter, beating analysts' consensus estimates of -$0.09 by $0.01.

  • What is the VolitionRx Limited stock price today?

    Today's price of VolitionRx Limited is $0.57 — it has decreased by -0.18% in the past 24 hours. Watch VolitionRx Limited stock price performance more closely on the chart.

  • Does VolitionRx Limited release reports?

    Yes, you can track VolitionRx Limited's financials in yearly and quarterly reports directly on Stocks.News.

  • What is the VolitionRx Limited stock forecast?

    Watch the VolitionRx Limited chart and read a more detailed VolitionRx Limited stock forecast to see what analysts suggest you do with its shares.

  • What is VolitionRx Limited stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on AMEX, exchange stock trades by VolitionRx Limited stock ticker.

  • How to buy VolitionRx Limited stocks?

    Like other stocks, VNRX shares are sold on stock exchanges such as AMEX. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is VolitionRx Limited's EBITDA?

    VolitionRx Limited measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in VolitionRx Limited’s financial statements.

  • What is the VolitionRx Limited's net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is -45.5552520179, which equates to approximately -4,555.53%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in VolitionRx Limited stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including VolitionRx Limited's financials relevant news, and technical analysis. VolitionRx Limited's technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for VolitionRx Limited stock currently indicates a “sell” signal. For more insights, review VolitionRx Limited’s technical analysis.

  • A revenue figure for VolitionRx Limited for its last quarter?

    VolitionRx Limited published it's last quarterly revenues at $474,522.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.